Each of the patients met the criteria for chronic possible estuary-associated syndrome (PEAS) following differential diagnosis, and responded positively to cholestyramine therapy.
Human visual function in the North Carolina Clinical Study on possible estuary-associated syndrome.
Since June 1, 1998, surveillance for possible estuary-associated syndrome
(PEAS), including possible Pp-related human illness, has been conducted in Delaware, Florida, Maryland, North Carolina, South Carolina, and Virginia.
Environmental public health surveillance: possible estuary-associated syndrome
CDC, in collaboration with other federal, state, and local government agencies and academic institutions, is conducting multistate surveillance, epidemiologic studies, and laboratory research for possible estuary-associated syndrome
(PEAS), including possible Pp-related human illness.
Her previous letter concerned our first EHP article (Shoemaker and Hudnell 2001) on possible estuary-associated syndrome
In "Possible Estuary-Associated Syndrome
: Symptoms, Vision, and Treatment," Shoemaker and Hudnell (1) advocated use of the visual contrast sensitivity (VCS) test as a biomarker to diagnose possible estuary-associated syndrome
(PEAS) and to assess response to their proposed treatment regimen.
15) reported that only these six cases with actual exposure met the CDC criteria for estuary-associated syndrome
, and that four had neuropsychologic impairment.
cholestyramine, chronic neurotoxic illness, harmful algal blooms, Pfiesteria, possible estuary-associated syndrome
, visual contrast sensitivity.
In their study, the North Carolina team used the 1997 Centers for Disease Control and Prevention case description for estuary-associated syndrome
EPA) and the National Institute for Occupational Health and Safety (NIOSH), formulated a case description for estuary-associated syndrome